Lv31
230 积分 2024-03-29 加入
Enhanced Recovery after Surgery — Evidence and Practice
4小时前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
11天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
29天前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
1个月前
已完结
Achievement of Guideline-Recommended Targets in Diabetes Care in China
1个月前
已完结
Positioning Oral Selective Estrogen Receptor Degraders in Patients with Metastatic Breast Cancer
3个月前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
3个月前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
4个月前
已完结
Radiofrequency: Thermage
4个月前
已完结
皖公网安备34019202002308
